KAIST medical scientists and their colleagues confirmed that the type I interferon response plays a pivotal role in exacerbating inflammation in severe COVID-19 cases. Severe COVID-19 has been shown to be caused by a hyper-inflammatory response. Particularly, inflammatory cytokines secreted by classical monocytes and macrophages are believed to play a crucial role in the severe progression of COVID-19.
A new single-cell RNA sequencing analysis of more than 59,000 cells from three different patient cohorts provided a detailed look at patients’ immune responses in severe cases of COVID-19. The results suggest that patients with severe cases of COVID-19 experience increased regulation of the type I interferon (IFN-I) inflammation-triggering pathway, a signature that the researchers also observed in patients hospitalized with severe cases of influenza.
Their findings suggest that anti-inflammatory treatment strategies for COVID-19 should also be aimed toward the IFN-I signaling pathway, in addition to targeting inflammatory molecules such as TNF, IL-1, and IL-6, which have been associated with COVID-19.
The research team under Professor Eui-Cheol Shin from the Graduate School of Medical Science and Engineering sequenced the RNA from a total of 59,572 blood cells obtained from four healthy donors, eight patients with mild or severe COVID-19, and five patients with severe influenza.
By comparison, patients with severe cases of influenza showed increased expression of various IFN-stimulated genes, but did not experience TNF/IL-1 responses as seen in COVID-19 patients. Unlike the flu cohort, patients in the severe COVID-19 cohort exhibited the IFN-I signature concurrently with TNF/IL-1-driven inflammation – a combination also not seen in patients with milder cases of COVID-19.
Their result, along with past mouse studies that highlight how the timing of IFN-I expression is critical to determining the outcome of SARS, support targeting IFN-I as a potential treatment strategy for severe COVID-19.
Professor Shin said, “This research provides insights for designing therapeutic options for COVID-19 by investigating very closely how the immune cells of COVDI-19 patients develop. We will continue to conduct research on novel therapeutic immune mechanisms and target therapeutic anti-inflammatory medication to improve the survival of severe COVID-19 patients.”
This study, conducted in collaboration with Severance Hospital at Yonsei University, Asan Medical Center, and Chungbuk National University, was featured in Science Immunology on July 10. This work was funded by Samsung Science and Technology Foundation and SUHF Fellowship.
< Figure: Analysis of blood immune cells at a single-cell level has revealed a cytokine signature associated with the development of severe COVID-19. >
Science Immunology 10 Jul 2020:
Vol. 5, Issue 49, eabd1554
Graduate School of Medical Science and Engineering
Laboratory of Immunology & Infectious Diseases (http://liid.kaist.ac.kr/)
The Center for Noise and Vibration Control at KAIST announced that their coughing detection camera recognizes where coughing happens, visualizing the locations. The resulting cough recognition camera can track and record information about the person who coughed, their location, and the number of coughs on a real-time basis. Professor Yong-Hwa Park from the Department of Mechanical Engineering developed a deep learning-based cough recognition model to classify a coughing sound in real time. T2020-08-13
KAIST announced that the university would continue online classes through the fall semester. However, the university will conduct additional in-person classes for upper-level undergraduate lab classes and some graduate courses where on-site interaction was deemed to be highly necessary. Some 600-level graduate courses at the Daejeon campus and graduate courses at the Seoul campus will carry out both in-person and online classes. The fall semester will start from August 31. Provost and Execut2020-07-10
If there is a silver lining behind the COVID-19 pandemic clouds engulfing the world in darkness, it would be ‘education’. The disruption caused by the pandemic has reminded us of the skills that students need in this unpredictable world and raised public awareness of guaranteeing continuous, fair, and quality learning opportunities. Educational innovation can become a positive and powerful catalyst to transform the world for a better future in the post-COVID era. According to the2020-06-24
Global leaders including the CEOs of Minerva and Coursera to join the KAIST online forum to discuss how to facilitate inclusive educational environment amidst the ever-growing digital disparities An international forum hosted by the KAIST Global Strategy Institute will examine how the disruptions caused by the global pandemic will impact the future of education. Global leaders will reflect on ways to better facilitate inclusive educational environments and mitigate the digital divide, especia2020-06-22
Reactive polymer-based tester pre-screens dsRNAs of a wide range of viruses without their genome sequences The prompt, precise, and massive detection of a virus is the key to combat infectious diseases such as Covid-19. A new viral diagnostic strategy using reactive polymer-grafted, double-stranded RNAs will serve as a pre-screening tester for a wide range of viruses with enhanced sensitivity. Currently, the most widely using viral detection methodology is polymerase chain reaction (PCR) dia2020-06-01